• 2025
  Lièvre G, Sicsic J, Galmiche S, Charmet T, Fontanet A, Mueller J, Are psychological attitudes towards vaccination an expression of personality? A cross-sectional study on COVID-19 vaccination in France., BMC Public Health 2025 Jan; 25(1): 209.
• 2024
  Galmiche S, Charmet T, Rakover A, Chény O, Omar F, David C, Mailles A, Carrat F, Fontanet A, Risk of SARS-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020-2022., BMC Public Health 2024 Sep; 24(1): 2411.
• 2024
  Perrey C, Mailles A, Septfons A, Charmet T, Cheny O, Von Platen C, Huet P, Lévy-Bruhl D, Galmiche S, Fontanet A, Jauffret-Roustide M, Contributions of the qualitative Qualicor study embedded in a cohort study on the circumstances of SARS-CoV 2 infection in France., Infect Dis Now 2024 Sep; 54(6): 104943.
• 2024
  Gaëlle Lièvre, Jonathan Sicsic, Simon Galmiche, Tiffany Charmet, Arnaud Fontanet, Judith Mueller, Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France, Vaccine, 2024, S0264-410X (24), pp.00438-9. ⟨10.1016/j.vaccine.2024.04.024⟩.
• 2024
  Rakover A, Galmiche S, Charmet T, Chény O, Omar F, David C, Martin S, Mailles A, Fontanet A, Source of SARS-CoV-2 infection: results from a series of 584,846 cases in France from October 2020 to August 2022., BMC Public Health 2024 Jan; 24(1): 325.
• 2023
  Galmiche S, Charmet T, Rakover A, Schaeffer L, Chény O, von Platen C, Omar F, David C, Mailles A, Carrat F, Fontanet A, Risk of SARS-CoV-2 Infection Among Households With Children in France, 2020-2022., JAMA Netw Open 2023 Sep; 6(9): e2334084.
• 2023
  Galmiche S, Thoreau B, Bretagne S, Alanio A, Paugam A, Letscher-Bru V, Cassaing S, Gangneux JP, Guegan H, Favennec L, Minoza A, Morio F, Bonhomme J, Desoubeaux G, Eloy O, Hasseine L, Sasso M, Millon L, Bellanger AP, Poirier P, Moniot M, Chouaki T, Huguenin A, Dalle F, Bouteille B, Nicolas M, Desbois-Nogard N, Bougnoux ME, Danion F, Poindron V, Néel A, Boukris-Sitbon K, Lanternier F, Terrier B, Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF network., RMD Open 2023 Aug; 9(3): .
• 2023
  Galmiche S, Cortier T, Charmet T, Schaeffer L, Chény O, von Platen C, Lévy A, Martin S, Omar F, David C, Mailles A, Carrat F, Cauchemez S, Fontanet A, SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study., Lancet Microbe 2023 Jun; 4(6): e409-e417.
• 2023
  Galmiche S, Charmet T, Mailles A, Fontanet A, Reply to: The role of pets in SARS-CoV-2 transmission: an exploratory analysis., Infection 2023 Jun; 51(3): 793-795.
• 2023
  Supplisson O, Charmet T, Galmiche S, Schaeffer L, Chény O, Lévy A, Jeandet N, Omar F, David C, Mailles A, Fontanet A, SARS-CoV-2 self-test uptake and factors associated with self-testing during Omicron BA.1 and BA.2 waves in France, January to May 2022., Euro Surveill 2023 May; 28(18): .
• 2022
  Grant R, Charmet T, Schaeffer L, Galmiche S, Madec Y, Von Platen C, Chény O, Omar F, David C, Rogoff A, Paireau J, Cauchemez S, Carrat F, Septfons A, Levy-Bruhl D, Mailles A, Fontanet A, , Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France., Lancet Reg Health Eur 2022 Feb; 13(): 100278.
• 2022
  Galmiche S, Luong Nguyen LB, Tartour E, de Lamballerie X, Wittkop L, Loubet P, Launay O, , Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review., Clin Microbiol Infect 2022 Feb; 28(2): 163-177.
• 2022
  Galmiche S, Fernandes-Pellerin S, Ungeheuer MN, Schwartz O, Attia M, Hoen B, High negative predictive value of RT-PCR in patients with high likelihood of SARS-CoV-2 infection., Infect Dis Now 2022 Feb; 52(1): 52-53.
• 2021
  Charmet T, Schaeffer L, Grant R, Galmiche S, Chény O, Von Platen C, Maurizot A, Rogoff A, Omar F, David C, Septfons A, Cauchemez S, Gaymard A, Lina B, Lefrancois LH, Enouf V, van der Werf S, Mailles A, Levy-Bruhl D, Carrat F, Fontanet A, , Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France., Lancet Reg Health Eur 2021 Sep; 8(): 100171.
• 2021
  Galmiche S, Charmet T, Schaeffer L, Paireau J, Grant R, Chény O, Von Platen C, Maurizot A, Blanc C, Dinis A, Martin S, Omar F, David C, Septfons A, Cauchemez S, Carrat F, Mailles A, Levy-Bruhl D, Fontanet A, , Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study., Lancet Reg Health Eur 2021 Aug; 7(): 100148.
• 2021
  Galmiche S, Bruel T, Madec Y, Tondeur L, Grzelak L, Staropoli I, Cailleau I, Ungeheuer MN, Renaudat C, Fernandes Pellerin S, Hoen B, Schwartz O, Fontanet A, , Characteristics Associated with Olfactory and Taste Disorders in COVID-19., Neuroepidemiology 2021 ; 55(5): 381-386.
• 2020
  Denis F, Galmiche S, Dinh A, Fontanet A, Scherpereel A, Benezit F, Lescure FX, , Epidemiological Observations on the Association Between Anosmia and COVID-19 Infection: Analysis of Data From a Self-Assessment Web Application., J Med Internet Res 2020 06; 22(6): e19855.
• 2019
  Galmiche S, Buob D, Fellahi S, Bastard JP, Grateau G, Georgin-Lavialle S, , Rheumatoid arthritis revealed by polyadenopathy, diarrhea and digestive AA amyloidosis., Joint Bone Spine 2019 05; 86(3): 397-398.
• 2016
  Bachmeyer C, Galmiche S, Fayand A, Degachi A, Georgin-Lavialle S, , Mycophenolate Mofetil in Refractory Cutaneous Lupus Erythematosus: No Definitive Evidence., J Rheumatol 2016 09; 43(9): 1766.